BELLINI, RACHELE
 Distribuzione geografica
Continente #
NA - Nord America 210
EU - Europa 180
AS - Asia 163
SA - Sud America 6
AF - Africa 2
Totale 561
Nazione #
US - Stati Uniti d'America 206
IT - Italia 86
SG - Singapore 83
HK - Hong Kong 57
IE - Irlanda 47
CN - Cina 12
RU - Federazione Russa 10
DE - Germania 9
FI - Finlandia 8
KR - Corea 5
NL - Olanda 5
BR - Brasile 4
AT - Austria 3
BE - Belgio 3
CA - Canada 3
AE - Emirati Arabi Uniti 1
AZ - Azerbaigian 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
EC - Ecuador 1
EE - Estonia 1
GA - Gabon 1
GR - Grecia 1
ID - Indonesia 1
IL - Israele 1
IM - Isola di Man 1
IR - Iran 1
MX - Messico 1
SA - Arabia Saudita 1
SE - Svezia 1
SK - Slovacchia (Repubblica Slovacca) 1
UA - Ucraina 1
UY - Uruguay 1
Totale 561
Città #
Singapore 65
Hong Kong 57
Perugia 44
Dublin 43
Chandler 40
Boardman 25
Santa Clara 16
Los Angeles 8
Seoul 5
Vicenza 5
Dallas 4
Florence 4
Helsinki 4
Lappeenranta 4
Medford 4
Munich 4
Naples 4
Princeton 4
San Mateo 4
Amsterdam 3
Bologna 3
Brussels 3
Vienna 3
Wilmington 3
Altamura 2
Frankfurt am Main 2
Houston 2
Lawrence 2
Menlo Park 2
Moscow 2
Rome 2
San Diego 2
Abidjan 1
Ann Arbor 1
Ashburn 1
Athens 1
Baku 1
Boydton 1
Bratislava 1
Brno 1
Cambridge 1
Den Haag 1
Douglas 1
Dubai 1
Duque de Caxias 1
Ercolano 1
Fremont 1
Guiyang 1
Jacksonville 1
Lugano 1
Montevideo 1
Newark 1
Nuremberg 1
Ottawa 1
Parauapebas 1
Philadelphia 1
Port-Gentil 1
Qingdao 1
Quito 1
Redmond 1
Riyadh 1
Seattle 1
São Paulo 1
Tallinn 1
Tel Aviv 1
Tenhult 1
Toledo 1
Toronto 1
Zanjan 1
Zhengzhou 1
Totale 413
Nome #
GLP-1 Mediates Regulation of Colonic ACE2 Expression by the Bile Acid Receptor GPBAR1 in Inflammation 54
Discovery of a AHR pelargonidin agonist that counter-regulates Ace2 expression and attenuates ACE2-SARS-CoV-2 interaction 51
Next-Generation Sequencing Analysis of Gastric Cancer Identifies the Leukemia Inhibitory Factor Receptor as a Driving Factor in Gastric Cancer Progression and as a Predictor of Poor Prognosis 45
Atorvastatin protects against liver and vascular damage in a model of diet induced steatohepatitis by resetting FXR and GPBAR1 signaling 44
Combinatorial therapy with BAR502 and UDCA resets FXR and GPBAR1 signaling and reverses liver histopathology in a model of NASH 42
Discovery of a Potent and Orally Active Dual GPBAR1/CysLT1R Modulator for the Treatment of Metabolic Fatty Liver Disease 42
Repositioning Mifepristone as a Leukaemia Inhibitory Factor Receptor Antagonist for the Treatment of Pancreatic Adenocarcinoma 38
Defective Bile Acid Signaling Promotes Vascular Dysfunction, Supporting a Role for G-Protein Bile Acid Receptor 1/Farnesoid X Receptor Agonism and Statins in the Treatment of Nonalcoholic Fatty Liver Disease 38
Discovery of BAR502, as potent steroidal antagonist of leukemia inhibitory factor receptor for the treatment of pancreatic adenocarcinoma 36
Combinatorial targeting of GPBAR1 and CYSLTR1 reveals a mechanistic role for bile acids and leukotrienes in drug induced liver injury 34
Beneficial effects of UDCA and norUDCA in a rodent model of steatosis are linked to modulation of GPBAR1/FXR signaling 32
Activation of GPBAR1 attenuates vascular inflammation and atherosclerosis in a mouse model of NAFLD-related cardiovascular disease 30
Discovery of a Novel Class of Dual GPBAR1 Agonists-RORγt Inverse Agonists for the Treatment of IL-17-Mediated Disorders 26
The leukemia inhibitory factor regulates fibroblast growth factor receptor 4 transcription in gastric cancer 21
Bile acids serve as endogenous antagonists of the Leukemia inhibitory factor (LIF) receptor in oncogenesis 19
Development of dual GPBAR1 agonist and RORγt inverse agonist for the treatment of inflammatory bowel diseases 16
Analysis of Oral and Gut Microbiota Composition in Children with Dental Caries by NGS Approaches 10
Liver GPBAR1 Associates With Immune Dysfunction in Primary Sclerosing Cholangitis and Its Activation Attenuates Cholestasis in Abcb4−/− Mice 9
Microbial-derived bile acid reverses inflammation in IBD via GPBAR1 agonism and RORγt inverse agonism 7
Totale 594
Categoria #
all - tutte 3.844
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.844


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20215 0 0 0 0 0 0 0 0 0 4 1 0
2021/202231 0 2 0 0 0 0 9 4 0 10 1 5
2022/2023170 9 13 0 9 21 17 0 7 82 0 6 6
2023/2024128 6 8 3 5 11 1 28 12 19 6 19 10
2024/2025260 6 29 25 17 25 40 33 43 42 0 0 0
Totale 594